Neratinib Completed Phase 1 / 2 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01423123Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
NCT00708903Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)